Anti-TNFRSF8 (Brentuximab-LC-N152)-DBCO-MMAF ADC
This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (Brentuximab variant,LC-N152) conjugated via a DBCO linker to MMAF. The MMAF is targeted to ceRoom Temperatureain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAF binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.
Product Specifications
Format
Solution
Shipping Conditions
Ice Packs
Storage Conditions
-20°C
CAS Number
9007-83-4
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
